Calendrier des promotions Artelo Biosciences, Inc.
Calendrier avancé
Graphique simple
À propos de l'entreprise Artelo Biosciences, Inc.
Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment of inflammatory bowel disease and post-traumatic stress disorder (PTSD); and ART26. plus de détails| IPO date | 2017-11-14 |
|---|---|
| ISIN | US04301G5080 |
| Industry | Pharmaceuticals |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.artelobio.com |
| Цена ао | 0.971 |
| Changement de prix par jour: | -2.59% (0.965) |
|---|---|
| Changement de prix par semaine: | -9.62% (1.04) |
| Changement de prix par mois: | -13.67% (1.0889) |
| Changement de prix sur 3 mois: | -11.32% (1.06) |
| Changement de prix sur six mois: | -16.09% (1.1202) |
| Changement de prix par an: | -36.49% (1.48) |
| Evolution du prix sur 3 ans: | +115.79% (0.4356) |
| Evolution du prix sur 5 ans: | -12.15% (1.07) |
| Evolution des prix depuis le début de l'année: | -3.09% (0.97) |
|
|
Sous-estimation
|
Efficacité
|
|||||||||||||||||||||||||||||||||||||
Dividendes
|
Devoir
|
Impulsion de croissance
|
|||||||||||||||||||||||||||||||||||||
| Établissements | Volume | Partager, % |
|---|---|---|
| Geode Capital Management, LLC | 19808 | 0.61 |
| Tower Research Capital LLC (TRC) | 4803 | 0.15 |
| Wells Fargo & Company | 22 | 0 |
| Morgan Stanley | 20 | 0 |
| Osaic Holdings Inc | 7 | 0 |
| NewEdge Advisors, LLC | 1 | 0 |
| Superviseur | Titre d'emploi | Paiement | Année de naissance |
|---|---|---|---|
| Mr. Gregory D. Gorgas M.B.A. | President, CEO, CFO, Treasurer, Secretary & Director | 742.45k | 1963 (62 année) |
| Dr. Andrew Yates Ph.D. | Senior VP & Chief Scientific Officer | N/A | |
| Dr. Steven D. Reich | Chief Medical Officer | N/A | 1946 (79 années) |
| Mr. Jason H. Baybutt | Senior Vice President of Finance | N/A | 1972 (53 année) |
Adresse: United States, Solana Beach. CA, 505 Lomas Santa Fe - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.artelobio.com
Site web: https://www.artelobio.com
